SENNA- sennosides tablet

SENNA by

Drug Labeling and Warnings

SENNA by is a Otc medication manufactured, distributed, or labeled by AARNA USA INC., KJD PHARMA PRIVATE LIMITED. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Active ingredient (in each tablet)

Sennosides 8.6 mg

Purpose

Laxative

Uses

• relieves occasional constipation (irregularity)
• generally causes a bowel movement in 6-12 hours

WARNINGS

Do not use

• laxative products for longer than one week unless directed by a doctor

Do not use

laxative products for longer than one week unless directed by a doctor

Ask a doctor before use if you have

• stomach pain
• nausea
• vomiting
• noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative.

These may indicate a serious condition.

If pregnant or breast-feeding,

ask a health care professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

take preferably at bedtime or as directed by a doctor

age	starting dosage	maximum dosage
Adults and children 12 years of age and older	2 tablets once a day	4 tablets twice a day
Children 6 to under 12 years of age	1 tablet once a day	2 tablets twice a day
Children 2 to under 6 years of age	1/2 tablet once a day	1 tablet twice a day
Children under 2 years of age	ask a doctor	ask a doctor

Other information

• Each tablet contains: Calcium 14 mg
• Store between 15º to 30ºC (59 to 86F)

Inactive ingredients

microcrystaline cellulose, dicalcium phosphate, sodium starch glycolate, croscarmellose sodium, hypromellose, povidone, collodial silicon dioxide, megnesium stearate. 

Questions or comments?

1-(877) 255-6999

SPL UNCLASSIFIED SECTION

Tamper Evident:

Do not use if imprinted inner safety seal is torn or missing.

This product is not manufactured or distributed by Purdue Products L.P.,

Owner of the registered trademark Senokot ®

Manufactured for:

Aarna USA Inc.

Leland, NC 28451

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

SENNA 
sennosides tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 82568-0006
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg

Inactive Ingredients
Ingredient Name	Strength
CROSPOVIDONE (UNII: 2S7830E561)
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: L11K75P92J)
HYDROXYPROPYL METHYLCELLULOSE (UNII: 3NXW29V3WO)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
POVIDONE (UNII: FZ989GH94E)
SODIUM STARCH GLYCOLATE TYPE A CORN (UNII: AG9B65PV6B)
STEARIC ACID (UNII: 4ELV7Z65AP)
TALC (UNII: 7SEV7J4R1U)

Product Characteristics
Color	brown	Score	no score
Shape	ROUND	Size	3mm
Flavor		Imprint Code	8;6;A
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 82568-0006-1	100 in 1 BOTTLE; Type 0: Not a Combination Product	05/29/2025
2	NDC: 82568-0006-2	1000 in 1 BOTTLE; Type 0: Not a Combination Product	05/29/2025
3	NDC: 82568-0006-3	100 in 1 PACKAGE	05/29/2025
3		1 in 1 PACKET; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M007	05/29/2025

Labeler - AARNA USA INC. (118515992)

Establishment
Name	Address	ID/FEI	Business Operations
KJD PHARMA PRIVATE LIMITED		877256314	manufacture(82568-0006)